167 related articles for article (PubMed ID: 11094455)
1. IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus?
Seery JP
Arthritis Res; 2000; 2(6):437-440. PubMed ID: 11094455
[TBL] [Abstract][Full Text] [Related]
2. A central role for alpha beta T cells in the pathogenesis of murine lupus.
Seery JP; Wang EC; Cattell V; Carroll JM; Owen MJ; Watt FM
J Immunol; 1999 Jun; 162(12):7241-8. PubMed ID: 10358171
[TBL] [Abstract][Full Text] [Related]
3. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
[TBL] [Abstract][Full Text] [Related]
4. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis.
Seery JP; Carroll JM; Cattell V; Watt FM
J Exp Med; 1997 Nov; 186(9):1451-9. PubMed ID: 9348302
[TBL] [Abstract][Full Text] [Related]
6. Murine models of cutaneous involvement in lupus erythematosus.
Ghoreishi M; Dutz JP
Autoimmun Rev; 2009 May; 8(6):484-7. PubMed ID: 19239927
[TBL] [Abstract][Full Text] [Related]
7. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
Nicoletti F; Di Marco R; Zaccone P; Xiang M; Magro G; Grasso S; Morrone S; Santoni A; Shoenfeld Y; Garotta G; Meroni P
Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
Han B; Moore PA; Wu J; Luo H
Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
[TBL] [Abstract][Full Text] [Related]
9. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
Amoura Z; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
[TBL] [Abstract][Full Text] [Related]
10. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
11. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S
Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
Haas C; Ryffel B; Le Hir M
J Immunol; 1998 Apr; 160(8):3713-8. PubMed ID: 9558072
[TBL] [Abstract][Full Text] [Related]
13. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
14. Nucleosomes in the pathogenesis of systemic lupus erythematosus.
Koutouzov S; Jeronimo AL; Campos H; Amoura Z
Rheum Dis Clin North Am; 2004 Aug; 30(3):529-58, ix. PubMed ID: 15261340
[TBL] [Abstract][Full Text] [Related]
15. Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells.
Suen JL; Chuang YH; Tsai BY; Yau PM; Chiang BL
Arthritis Rheum; 2004 Oct; 50(10):3250-9. PubMed ID: 15476240
[TBL] [Abstract][Full Text] [Related]
16. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis.
Ozmen L; Roman D; Fountoulakis M; Schmid G; Ryffel B; Garotta G
Eur J Immunol; 1995 Jan; 25(1):6-12. PubMed ID: 7843255
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
Wither J; Vukusic B
J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
19. [Cytokines in systemic lupus erythematosus].
Robak E; Sysa-Jedrzejowska A; Robak T
Przegl Lek; 1996; 53(8):623-6. PubMed ID: 8999465
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
Mikita N; Ikeda T; Ishiguro M; Furukawa F
J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
